J&J Pharma Goes Into Play

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Johnson & Johnson has confirmed a review of its pharmaceuticals business.

Marc Monseau, a J&J rep, issued this statement late Friday: “As part of our ongoing efforts to leverage the best creative talent in advertising and marketing and to enhance efficiencies through a more integrated approach, we are undertaking a review of the creative and marketing agencies that support our pharmaceuticals group. It is premature to say what the outcome will be.”

He declined to discuss the matter in detail with Adweek.

The group includes Procrit, Topomax and Ultram, and estimated annual marketing support likely tops $100 million.

Agency

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in